FDA Import Refusal 799-6809312-8/11/3 — CSPC Ouyi Pharmaceutical Co., Ltd.
The FDA refused shipment 799-6809312-8/11/3 from CSPC Ouyi Pharmaceutical Co., Ltd. (China) on May 13, 2020. The refused product falls under Drugs and Biologics — ESTRAMUSTINE PHOSPHATE SODIUM (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 13, 2020
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 62ICY76 ESTRAMUSTINE PHOSPHATE SODIUM (ANTI-NEOPLASTIC)
- Charges
- 75